Top 20 Companies in Global Glucagon-Like Peptide-1 Agonists Market (20262035): Expert View By Spherical Insights RELEASE DATE: May 2026 Author: Spherical Insights According to a research report published by Spherical Insights & Consulting, The Global Glucagon-Like Peptide-1 Agonists Market size is projected to grow from USD 46.18 Billion in 2025 to USD 160.42 Billion by 2035, at a CAGR of 13.28% during the forecast period 20262035
Patients in the phase 3b clinical trial maintained about 75-80% of their weight loss and health benefits, such as reduced waist circumference and improvements in blood pressure, blood sugar, triglycerides and cholesterol levels
however, the price hike has proven insufficient to address the downturn in product sales
Rising adoption of oral GLP-1 drugs The growing take up of oral GLP-1 medicines is, in a way, re-shaping the global GLP-1 agonists market
is one of those big global pharma companies that keeps working on new medicines and healthcare products, across a bunch of therapeutic areas
It works by mimicking the action of the GLP-1 hormone, which regulates appetite and food intake
